Blueprint for Diabetic Sovereignty. Dieser Artikel ist nicht verfügbar.Blueprint for Diabetic Sovereignty

Take control of insulin. Take control of the future.

The U.S. insulin supply chain is vulnerable — dominated by three pharmaceutical giants and reliant on international components. In a post-COVID world where supply shocks and rising prices are the norm, millions of diabetics are left exposed. Blueprint for Diabetic Sovereignty offers a bold solution.

This book is the first of its kind: a practical, step-by-step guide to building a U.S.-based insulin production facility using American resources, talent, and infrastructure.

Written by a Type 1 diabetic with a background in business strategy and systems design, this book lays out everything an entrepreneur, investor, or health policy advocate needs to know to bring insulin production home — and put healthcare security into the hands of the people who need it most.

Inside this book, you'll discover:

• How to source all essential insulin components domestically
• A complete facility design and regulatory roadmap (including FDA and GMP compliance)
• Cost models, funding strategies, and site selection breakdowns
• Historical insights and future forecasts on the insulin market
• Why domestic insulin production isn’t just possible — it’s essential

Whether you’re a biotech visionary, a public health advocate, or a problem-solver looking to make real impact, this is more than a business manual — it’s a declaration of independence for American healthcare.

Because America's healthcare security should be made in America.
Part of the "Vital Supply Lines" series